|
Volumn 8, Issue 4, 2002, Pages 327-328
|
New anti-HSV therapeutics target the helicase-primase complex
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
ANTIVIRUS AGENT;
BAY 57 1293;
BILS 179 BS;
DNA PRIMASE;
HELICASE;
NEW DRUG;
NUCLEOSIDE ANALOG;
THIAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
UREA DERIVATIVE;
VALACICLOVIR;
ANTIVIRAL ACTIVITY;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG SAFETY;
DRUG SPECIFICITY;
DRUG TARGETING;
HERPES VIRUS INFECTION;
HUMAN;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
SIDE EFFECT;
ACYCLOVIR;
ANIMALS;
ANTIVIRAL AGENTS;
DNA HELICASES;
DNA PRIMASE;
DNA REPLICATION;
DNA, VIRAL;
HERPES SIMPLEX;
HUMANS;
MACROMOLECULAR SUBSTANCES;
SIMPLEXVIRUS;
VIRAL PROTEINS;
VIRUS REPLICATION;
ANIMALIA;
HERPESVIRIDAE;
SIMPLEXVIRUS;
|
EID: 0036109158
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0402-327 Document Type: Short Survey |
Times cited : (47)
|
References (11)
|